Powered by OpenAIRE graph
Found an issue? Give us feedback

A phase III multi centre double-blind placebo controlled study analysing the efficacy and safety of daily administration of a P2Y12 inhibitor (clopidogrel) for the treatment of pancreatic cancer

Funder: Institut National du CancerProject code: INCa-DGOS-7310 Call for proposal: PHRC13
Funded under: PHRC

A phase III multi centre double-blind placebo controlled study analysing the efficacy and safety of daily administration of a P2Y12 inhibitor (clopidogrel) for the treatment of pancreatic cancer

Powered by OpenAIRE graph
Found an issue? Give us feedback

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

All Research products
arrow_drop_down
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=inca________::87c0e9d8efd0c9b6d3bca3ed9b850600&type=result"></script>');
-->
</script>
For further information contact us at helpdesk@openaire.eu

No option selected
arrow_drop_down